Literature DB >> 11509651

Control of the autoimmune response by type 2 nitric oxide synthase.

F D Shi1, M Flodström, S H Kim, S Pakala, M Cleary, H G Ljunggren, N Sarvetnick.   

Abstract

Immune defense against pathogens often requires NO, synthesized by type 2 NO synthase (NOS2). To discern whether this axis could participate in an autoimmune response, we immunized NOS2-deficient mice with the autoantigen acetylcholine receptor, inducing muscle weakness characteristic of myasthenia gravis, a T cell-dependent Ab-mediated autoimmune disease. We found that the acetylcholine receptor-immunized NOS2-deficient mice developed an exacerbated form of myasthenia gravis, and demonstrated that NOS2 expression limits autoreactive T cell determinant spreading and diversification of the autoantibody repertoire, a process driven by macrophages. Thus, NOS2/NO is important for silencing autoreactive T cells and may restrict bystander autoimmune reactions following the innate immune response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509651     DOI: 10.4049/jimmunol.167.5.3000

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Nitric oxide regulates BAFF expression and T cell-independent antibody responses.

Authors:  Daniela Giordano; Kevin E Draves; Chang Li; Tobias M Hohl; Edward A Clark
Journal:  J Immunol       Date:  2014-06-20       Impact factor: 5.422

2.  Nitric oxide and cGMP protein kinase (cGK) regulate dendritic-cell migration toward the lymph-node-directing chemokine CCL19.

Authors:  Daniela Giordano; Dario M Magaletti; Edward A Clark
Journal:  Blood       Date:  2005-10-25       Impact factor: 22.113

3.  Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Jason R Mock; Yoshiki Eto; Brian T Garibaldi; Daniel C Files; Claudia R Avalos; Jackie V Rodriguez; Adam T Waickman; Sekhar P Reddy; David B Pearse; Venkataramana K Sidhaye; Paul M Hassoun; Michael T Crow; Landon S King
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

Review 4.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

5.  S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis.

Authors:  Narender Nath; Osamu Morinaga; Inderjit Singh
Journal:  J Neuroimmune Pharmacol       Date:  2010-01-21       Impact factor: 4.147

6.  TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy.

Authors:  Martina Molgora; Ekaterina Esaulova; William Vermi; Jinchao Hou; Yun Chen; Jingqin Luo; Simone Brioschi; Mattia Bugatti; Andrea Salvatore Omodei; Biancamaria Ricci; Catrina Fronick; Santosh K Panda; Yoshiko Takeuchi; Matthew M Gubin; Roberta Faccio; Marina Cella; Susan Gilfillan; Emil R Unanue; Maxim N Artyomov; Robert D Schreiber; Marco Colonna
Journal:  Cell       Date:  2020-08-11       Impact factor: 41.582

7.  Positive and negative regulation of T cell responses by fibroblastic reticular cells within paracortical regions of lymph nodes.

Authors:  Stefanie Siegert; Sanjiv A Luther
Journal:  Front Immunol       Date:  2012-09-11       Impact factor: 7.561

8.  Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide.

Authors:  Stefanie Siegert; Hsin-Ying Huang; Chen-Ying Yang; Leonardo Scarpellino; Lucie Carrie; Sarah Essex; Peter J Nelson; Matthias Heikenwalder; Hans Acha-Orbea; Christopher D Buckley; Benjamin J Marsland; Dietmar Zehn; Sanjiv A Luther
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.